NYSEFinancialsLife & Health InsuranceS&P MidCap 400
$55.45
-0.98 (-1.74%)
Close of Nov 06, 2026 · end-of-day data
Source: CNO Financial Group's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$3.99B
$4.30B
$4.31B
$4.02B
$3.82B
$4.12B
$3.58B
$4.15B
$4.45B
$4.49B
Operating income
—
$454.70M
$381.20M
$368.30M
$463.80M
$514.70M
$466.70M
$459.50M
$550.80M
$553.20M
Interest expense
$116.40M
$123.70M
$149.80M
$152.30M
$108.80M
$95.40M
$137.00M
$238.60M
$254.40M
$230.90M
Pre-tax income
$353.20M
$480.50M
-$264.80M
$274.20M
$344.30M
$733.10M
$816.50M
$356.80M
$539.90M
$293.40M
Income tax
-$5.00M
$304.90M
$50.20M
-$135.20M
$42.50M
$162.80M
$185.90M
$80.30M
$119.10M
$64.10M
Net income
$358.20M
$175.60M
-$315.00M
$409.40M
$301.80M
$570.30M
$630.60M
$276.50M
$420.80M
$229.30M
EBITDA
—
$720.10M
$673.40M
$636.20M
$767.70M
$751.30M
$715.20M
$726.90M
$843.20M
$871.70M
EPS (basic)
$2.03
$1.03
$-1.90
$2.62
$2.12
$4.44
$5.45
$2.44
$3.96
$2.35
EPS (diluted)
$2.01
$1.02
$-1.90
$2.61
$2.11
$4.35
$5.36
$2.40
$3.89
$2.30
Diluted shares
178.32M
172.14M
165.46M
157.15M
143.16M
131.13M
117.72M
115.12M
108.12M
99.82M
Operating margin
—
10.6%
8.8%
9.2%
12.1%
12.5%
13.0%
11.1%
12.4%
12.3%
Net margin
9.0%
4.1%
-7.3%
10.2%
7.9%
13.8%
17.6%
6.7%
9.5%
5.1%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$668.20M
$757.30M
$656.60M
$654.70M
$991.90M
$731.70M
$644.90M
$889.00M
$2.00B
$983.50M
Total assets
$31.98B
$33.11B
$31.44B
$33.63B
$35.34B
$36.20B
$33.13B
$35.03B
$37.85B
$38.79B
Long-term debt
$912.90M
$914.60M
$916.80M
—
—
—
—
—
—
—
Total debt
$912.90M
$914.60M
$916.80M
—
—
—
—
—
—
—
Total liabilities
$27.49B
$28.26B
$28.07B
$28.95B
$29.86B
$30.94B
$31.36B
$32.81B
$35.33B
$36.15B
Shareholders' equity
$4.49B
$4.85B
$3.37B
$4.68B
$5.48B
$3.68B
$1.77B
$2.22B
$2.52B
$2.64B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$775.70M
$633.30M
$317.80M
$696.70M
$735.50M
$598.30M
$495.40M
$582.90M
$627.70M
$675.70M
Free cash flow
$775.70M
$633.30M
$317.80M
$696.70M
$735.50M
$598.30M
$495.40M
$582.90M
$627.70M
$675.70M
Investing cash flow
-$930.40M
-$270.20M
-$525.70M
-$555.60M
-$608.40M
-$1.53B
-$1.78B
-$872.30M
-$1.49B
-$1.67B
Financing cash flow
$26.20M
-$274.00M
$107.20M
-$143.00M
$210.10M
$667.60M
$1.20B
$533.50M
$1.97B
-$22.60M
Dividends paid
$54.80M
$59.60M
$64.80M
$67.10M
$67.00M
$65.70M
$64.80M
$68.10M
$67.70M
$66.20M
Share buybacks
$210.00M
$168.30M
$108.00M
$254.50M
$268.30M
$407.80M
$190.10M
$166.10M
$300.20M
$331.40M
Depreciation & amortization
$275.00M
$265.40M
$292.20M
$267.90M
$303.90M
$236.60M
$248.50M
$267.40M
$292.40M
$318.50M
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$1.17B
$1.16B
$1.07B
$1.13B
$1.10B
$1.00B
$1.15B
$1.19B
$1.14B
$1.03B
$1.29B
$1.09B
Operating income
$172.10M
$74.80M
$148.60M
$153.50M
$173.90M
$104.60M
$112.30M
$162.80M
$173.50M
$129.90M
$151.00M
$220.20M
Interest expense
$63.70M
$60.20M
$64.20M
$68.00M
$62.00M
$62.00M
$59.10M
$56.60M
$53.20M
$50.90M
$55.30M
$58.10M
Pre-tax income
$46.10M
$146.20M
$150.60M
$11.00M
$232.10M
$27.80M
$118.00M
$36.20M
$111.40M
$48.40M
$159.70M
$226.40M
Income tax
$9.80M
$33.90M
$34.30M
$1.70M
$44.40M
$6.30M
$26.20M
$13.10M
$18.50M
$10.70M
$33.80M
$65.30M
Net income
$36.30M
$112.30M
$116.30M
$9.30M
$182.90M
$21.50M
$91.80M
$23.10M
$92.90M
$37.70M
$125.90M
$161.10M
EBITDA
$241.00M
$145.20M
$220.10M
$227.90M
$250.00M
$182.40M
$191.10M
$242.90M
$255.30M
$213.30M
$235.10M
$305.00M
EPS (basic)
$0.33
$1.03
$1.08
$0.09
$1.78
$0.21
$0.93
$0.24
$0.98
$0.40
$1.35
$1.75
EPS (diluted)
$0.32
$1.01
$1.06
$0.09
$1.74
$0.21
$0.91
$0.24
$0.95
$0.39
$1.33
$1.71
Diluted shares
-489.00K
110.84M
109.26M
107.13M
-962.00K
103.07M
100.39M
98.55M
-848.00K
96.14M
94.95M
94.25M
Operating margin
14.7%
6.5%
13.9%
13.6%
15.8%
10.4%
9.8%
13.7%
15.2%
12.6%
11.7%
20.3%
Net margin
3.1%
9.7%
10.9%
0.8%
16.7%
2.1%
8.0%
1.9%
8.1%
3.7%
9.8%
14.8%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$889.00M
$649.80M
$992.10M
$1.25B
$2.00B
$1.02B
$816.00M
$1.24B
$983.50M
$1.15B
$1.31B
$1.42B
Goodwill
—
—
—
—
—
—
—
$69.50M
—
—
—
—
Total assets
$35.03B
$34.94B
$36.29B
$37.65B
$37.85B
$37.44B
$37.33B
$38.30B
$38.79B
$38.96B
$39.86B
$39.31B
Total liabilities
$32.81B
$32.57B
$33.86B
$34.96B
$35.33B
$34.91B
$34.81B
$35.69B
$36.15B
$36.47B
$37.27B
$36.98B
Shareholders' equity
$2.22B
$2.37B
$2.43B
$2.69B
$2.52B
$2.56B
$2.52B
$2.61B
$2.64B
$2.50B
$2.59B
$2.32B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$176.70M
$94.60M
$110.90M
$231.20M
$191.00M
$136.70M
$145.50M
$197.80M
$195.70M
$148.80M
$156.60M
$242.00M
Free cash flow
$176.70M
$94.60M
$110.90M
$231.20M
$191.00M
$136.70M
$145.50M
$197.80M
$195.70M
$148.80M
$156.60M
$242.00M
Investing cash flow
$73.00M
-$23.60M
-$1.15B
-$167.90M
-$151.20M
-$538.20M
-$122.20M
-$106.10M
-$900.80M
-$184.10M
-$603.70M
-$468.30M
Financing cash flow
$56.50M
-$310.20M
$1.38B
$189.90M
$712.60M
-$571.40M
-$232.10M
$333.90M
$447.00M
$206.10M
$598.80M
$341.70M
Dividends paid
$16.70M
$17.30M
$17.20M
$16.80M
$16.40M
$16.90M
$16.70M
$16.40M
$16.20M
$17.10M
$16.70M
$16.60M
Share buybacks
$70.30M
$58.80M
$59.80M
$89.90M
$91.70M
$110.30M
$100.30M
$60.60M
$60.20M
$73.30M
$60.90M
$59.50M
Depreciation & amortization
$68.90M
$70.40M
$71.50M
$74.40M
$76.10M
$77.80M
$78.80M
$80.10M
$81.80M
$83.40M
$84.10M
$84.80M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.